Suppr超能文献

8-(脯氨酸/吡唑)取代黄嘌呤衍生物的支气管解痉和腺苷结合活性

Bronchospasmolytic and Adenosine Binding Activity of 8- (Proline / Pyrazole)- Substituted Xanthine Derivatives.

作者信息

Singh Sneha, Ojha Madhwi, Yadav Divya, Kachler Sonja, Klotz Karl-Norbert, Yadav Rakesh

机构信息

Department of Pharmacy, Banasthali Vidyapith, Banasthali-304022, Rajasthan, India.

Institut für Pharmakologie und Toxikologie, Universität Würzburg, Würzburg, Germany.

出版信息

Curr Drug Discov Technol. 2021;18(5):e22092020186181. doi: 10.2174/1570163817666200922121005.

Abstract

BACKGROUND

8-Phenyltheophylline derivatives exhibit prophylactic effects at a specific dose but do not produce the cardiovascular or emetic side effects associated with xanthines, thereby exhibiting unique characteristics of potential therapeutic importance.

METHODS

Novel series of 8-(proline/pyrazole)-substituted xanthine analogs have been synthesized. The affinity and selectivity of compounds to adenosine receptors have been assessed by radioligand binding studies. The synthesized compounds also showed good bronchospasmolytic properties (increased onset of bronchospasm; decreased duration of jerks) with 100% survival of animals in comparison to the standard drug. Besides, compound 8f & 9f showed good binding affinity in comparison to other synthesized compounds in the micromolar range.

RESULTS

The maximum binding affinity of these compounds was observed for A2B receptors, which was ~ 7 or 10 times higher as compared to A1, A2A and A3 receptors. The newly synthesized derivatives 8f, 9a-f, 17g-m, and 18g-m displayed significant protection against histamine aerosol induced bronchospasm in guinea pigs.

CONCLUSION

Newly synthesized proline/pyrazole based xanthines compounds showed a satisfactory binding affinity for adenosine receptor subtypes. Replacement or variation of substituted proline ring with substituted pyrazole scaffold at the 8th-position of xanthine moiety resulted in the reduction of adenosine binding affinity and bronchospasmolytic effects.

摘要

背景

8-苯基茶碱衍生物在特定剂量下具有预防作用,且不会产生与黄嘌呤相关的心血管或催吐副作用,因此展现出具有潜在治疗重要性的独特特性。

方法

已合成了一系列新型的8-(脯氨酸/吡唑)取代的黄嘌呤类似物。通过放射性配体结合研究评估了化合物对腺苷受体的亲和力和选择性。与标准药物相比,合成的化合物还表现出良好的支气管解痉特性(支气管痉挛发作增加;抽搐持续时间缩短),动物存活率达100%。此外,与其他合成化合物相比,化合物8f和9f在微摩尔范围内显示出良好的结合亲和力。

结果

观察到这些化合物对A2B受体的最大结合亲和力,与A1、A2A和A3受体相比高约7倍或10倍。新合成的衍生物8f、9a-f、17g-m和18g-m对组胺气雾剂诱导的豚鼠支气管痉挛具有显著的保护作用。

结论

新合成的基于脯氨酸/吡唑的黄嘌呤化合物对腺苷受体亚型表现出令人满意的结合亲和力。在黄嘌呤部分的第8位用取代的吡唑支架取代或改变取代的脯氨酸环会导致腺苷结合亲和力和支气管解痉作用降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验